AVEN Antikörper (N-Term)

Produktnummer ABIN1881095

Produktdetails anti-AVEN Antikörper

Target: AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))

Bindungsspezifität: AA 78-106, N-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser AVEN Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen: This AVEN antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 78-106 amino acids from the N-terminal region of human AVEN.

Klon: RB41905

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: WB: 1:1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Haltbarkeit: 6 months

Referenzen für anti-AVEN Antikörper (ABIN1881095)

Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).

Ruaño, Thompson, Kane, Pullinger, Windemuth, Seip, Kocherla, Holford, Wu: "Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?" in: Pharmacogenomics, Vol. 11, Issue 7, pp. 959-71, (2010) (PubMed).

Sugarbaker, Richards, Gordon, Dong, De Rienzo, Maulik, Glickman, Chirieac, Hartman, Taillon, Du, Bouffard, Kingsmore, Miller, Farmer, Jensen, Gullans, Bueno: "Transcriptome sequencing of malignant pleural mesothelioma tumors." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 9, pp. 3521-6, (2008) (PubMed).

Details zu AVEN

Target: AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))

Andere Bezeichnung: AVEN (AVEN Produkte)

Synonyme: AVEN antikoerper, pdcd12 antikoerper, aven antikoerper, wu:fc08c09 antikoerper, si:ch211-150c22.4 antikoerper, PDCD12 antikoerper, 1700013A01Rik antikoerper, 1700056A21Rik antikoerper, mAven-L antikoerper, mAven-S antikoerper, apoptosis and caspase activation inhibitor antikoerper, apoptosis, caspase activation inhibitor L homeolog antikoerper, apoptosis, caspase activation inhibitor antikoerper, Aven antikoerper, AVEN antikoerper, aven.L antikoerper, aven antikoerper

Hintergrund: AVEN protects against apoptosis mediated by Apaf-1.

NCBI Accession: NP_065104

UniProt: Q9NQS1